All Videos Channels
  1. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    19
  2. Novo Nordisk wzywa nas do usunięcia filmów, pod groźbą kary!! Zaczęło się!

    Novo Nordisk wzywa nas do usunięcia filmów, pod groźbą kary!! Zaczęło się!

    78
    0
    2.49K
    3
  3. Wegovy heart benefits due to more than weight loss -Novo Nordisk

    Wegovy heart benefits due to more than weight loss -Novo Nordisk

    4
    0
    2K
    1
  4. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    27
  5. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    20
  6. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    21
  7. BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    BMO’s Evan David Seigerman cuts Novo Nordisk price target after Cagrisema data disappoints

    18
  8. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    21
  9. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    26
  10. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  11. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  12. Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    20
  13. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    12
  14. Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    Novo Nordisk Selloff Is an Overreaction, Barclays' Field Says

    16
  15. Novo Nordisk's New Obesity Drug: Game Changer? #shorts

    Novo Nordisk's New Obesity Drug: Game Changer? #shorts

    12
  16. Dr. Fatima Stamford, the Head of Obesity Research at Harvard is Paid Off by Novo Nordisk

    Dr. Fatima Stamford, the Head of Obesity Research at Harvard is Paid Off by Novo Nordisk

    103
    0
    5.47K
    9
  17. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    25
  18. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    22
  19. Novo Nordisk stock plunges on obesity shot trial results

    Novo Nordisk stock plunges on obesity shot trial results

    20
  20. Novo Nordisk's New Weight Drug Disappoints | World Business Watch

    Novo Nordisk's New Weight Drug Disappoints | World Business Watch

    25